Press release
Idiopathic Membranous Nephropathy Treatment Market to Witness Significant Growth with R&D in Idiopathic Membranous Nephropathy
Idiopathic membranous nephropathy a glomerular disease usually of abrupt onset and associated with the nephrotic syndrome. Membranous nephropathy occurs when the small blood vessels in the kidney (glomeruli), which filter wastes from the blood, become damaged and thickened. As a result, proteins leak from the damaged blood vessels into the urine (proteinuria).R&D in idiopathic membranous nephropathy is expected to aid in growth of the idiopathic membranous nephropathy treatment market. In July 2019, the study, ‘Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy’ stated that rituximab as effective as cyclosporine in inducing complete or partial remission of proteinuria at 12 months and was superior in maintaining proteinuria remission up to 24 months.
Most leading manufactures in the idiopathic membranous nephropathy treatment market are involved in the production of medicines for treatment of idiopathic membranous nephropathy. Recent clinical trials have shown that medicines which act on the musculoskeletal system can provide a rapid relief of symptoms in patients with mild to moderate nephrolithiasis. Advancing research and developments in this area is anticipated to support the worldwide, large-scale, commercialize idiopathic membranous nephropathy treatment market.
In November 2019, Novartis Pharmaceuticals imitated a randomized study evaluating the efficacy and safety of LNP023 compared with rituximab in subjects with membranous nephropathy who are at high risk of disease progression defined on the basis of antibody anti-PLA2R titre and proteinuria.
The idiopathic membranous nephropathy treatment market in Asia Pacific is also driven by R&D of new drugs. In June 2018, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, initiated a random trial to assess the urine protein remission rate of tacrolimus monotherapy for idiopathic membranous nephropathy. In December 2020, ValenzaBio, a privately-held biopharmaceutical company developing therapies for autoimmune and inflammatory diseases, initiated a Phase 1b/2a, open-label, sequential-cohort, dose escalation, and dose expansion study to evaluate the safety, tolerability, PK, and PD of VB119 in subjects with primary membranous nephropathy. VB119 is a humanized, immunoglobin (Ig) G1 monoclonal antibody (mAb) that can be administered as intravenous infusion at multiple timepoints during the study.
In November 2020, Hoffmann-La Roche, a major player in the idiopathic membranous nephropathy treatment market, initiated a study to evaluate the efficacy, safety, pharmacodynamics, and pharmacokinetics (PK) of obinutuzumab compared with tacrolimus in participants with primary membranous nephropathy.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Idiopathic Membranous Nephropathy Treatment Market to Witness Significant Growth with R&D in Idiopathic Membranous Nephropathy here
News-ID: 2346672 • Views: …
More Releases from Coherent Market Insights

Meal Replacement Market Market to Hit $22.01 Bn by 2032 with a CAGR of 5.8% |Abb …
The Meal Replacement Market is estimated to be valued at USD 14.82 Bn in 2025 and is expected to reach USD 22.01 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.8% from 2025 to 2032.
The latest report from Coherent Market Insights examines the growth prospects of the Meal Replacement Market Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends, key growth…

Deep Cycle Battery Market, Market Outlook : Projected to Exceed USD 4.73 Billion …
The deep cycle battery market is estimated to be valued at USD 2.77 billion in 2025 and is expected to reach USD 4.73 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.9% from 2025 to 2032.
The latest report from Coherent Market Insights examines the growth prospects of the Deep Cycle Battery Market, Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business…

Consumer Electronics Packaging Market Market Projected to Witness Huge Growth by …
The consumer electronics packaging market is estimated to be valued at USD 26.57 Bn in 2025 and is expected to reach USD 81.72 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 17.4% from 2025 to 2032.
The latest report from Coherent Market Insights examines the growth prospects of the Consumer Electronics Packaging Market Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends,…

Ceramic Armor Market Market Set to Witness Significant Growth by 2025-2032 |Koni …
The global ceramic armor market is estimated to be valued at USD 2.75 Bn in 2025 and is expected to reach USD 4.08 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.8% from 2025 to 2032.
The latest report from Coherent Market Insights examines the growth prospects of the Ceramic Armor Market Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends,…
More Releases for Membranous
Membranous Nephropathy Market Positioned for Accelerated Development Through 203 …
DelveInsight's "Membranous Nephropathy Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Membranous Nephropathy, historical and forecasted epidemiology as well as the Membranous Nephropathy market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Membranous Nephropathy market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Membranous Nephropathy Market Forecast
https://www.delveinsight.com/sample-request/membranous-nephropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Membranous Nephropathy Market Positioned for Accelerated Development Through 203 …
DelveInsight's "Membranous Nephropathy Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Membranous Nephropathy, historical and forecasted epidemiology as well as the Membranous Nephropathy market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Membranous Nephropathy market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Membranous Nephropathy Market Forecast
https://www.delveinsight.com/sample-request/membranous-nephropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Idiopathic Membranous Nephropathy Market Size And Global Industry Forecast 2034
Introduction
The Idiopathic Membranous Nephropathy (IMN) Market is experiencing steady growth as medical research advances understanding of this rare, immune-mediated kidney disorder. IMN, a leading cause of nephrotic syndrome in adults, is characterized by immune complex deposits on the glomerular basement membrane, leading to proteinuria and potential progression to kidney failure. Rising adoption of biomarker-driven diagnostics, targeted therapies, and increasing awareness in nephrology are expected to expand treatment adoption globally.
Download Full…
Membranous Nephropathy Market Forecasted for Consistent CAGR through 2024-2031
Membranous Nephropathy Market analysis, according to DataM Intelligence, offers more than just an overview; it investigates the underlying aspects of the sector. The study provides an overview, the research explores the hidden aspects of the sector, breaking down its intricate dynamics, charting regional dominance, spotting demand patterns, and spotting prospective breakthroughs that could influence how businesses operate in the future.
Will the Membranous Nephropathy market emerge as the sector's next great…
Membranous Nephropathy Market Forecast period 2022-2029.
The report is designed to provide a holistic view of the Membranous Nephropathy Market It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; revenue, demands, and supply data (as applicable). Regional estimates and forecasts & trend analysis for eac country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, Rest of Europe, Japan, China, South…
Membranous Nephropathy Market Report Covers Future Trends with Research 2023-203 …
Market Research, INC. has recently published a report on Membranous Nephropathy market which is an essential tool for businesses to gather critical insights about their target markets, competitors, and industry trends. With the increasing complexity of the global business environment, companies need accurate and up-to-date information to make informed decisions and stay ahead of the competition. That's why we are excited to announce the release of our latest market research…